Mergermarket Private Equity and M&A Forum Germany

Our flagship event for key players in the German private equity and M&A market

Marriott Hotel, Frankfurt, 60486

23 Apr

Panel: German ECM outlook – Where are the exit opportunities for private equity funds?

The European IPO market was subdued in 2023, but several European companies are expected to launch rights issues in 2024 after a slowdown in cash call activity in 2023. In Germany, only three companies listed in 2023 – Ionos, Thyssenkrupp Nucera, and Schott Pharma. The total issuance volume significantly decreased to €1.9bn, marking the second-lowest value in the past ten years. Hope is directed towards 2024 with perfume chain Douglas and long-distance bus operator Flix prepared for IPOs. Techem and Stada might transition to the stock market from private equity ownership. DKV Mobility and Personio are also said to be considering their positions.  

  • What are the reasons for such low ECM activity in Germany recently? Are IPOs still an attractive exit option for private equity funds? 
  • How are industry-specific dynamics affecting IPO activity in the DACH region? What other exit opportunities remain attractive? 
  • How are alternative funding methods, such as SPACs and direct listings, impacting the traditional IPO landscape? 
  • Are private equity funds considering dual-track processes when they are considering exits?
image
  • Speakers keyboard_arrow_down
    image
    Samuel Kerr Senior ECM Editor MERGERMARKET & DEALOGIC Bio